Publication date: Available online 11 September 2026 Source: Journal of Cystic Fibrosis Author(s): Hermann Bihler, Andrey Sivachenko, Priyanka Bhatt, Ashley Baldwin, Jan Harrington, Violaine Bailey, Alexi Panagiotou, Divesh Patel, Michael J. Mulligan, Rachel Valdez Misiolek, Kylie Arnold, Yi Cheng, Kevin Coote, Normand E. Allaire, Joshua Conte, Karen S. Raraigh, Garry R. Cutting, Martin Mense
In Vitro Responsiveness of 417 CFTR Variants to Vanzacaftor/Tezacaftor/Ivacaftor. // Journal of Cystic Fibrosis. – URL: https://www.sciencedirect.com/science/article/pii/S1569199326037318?dgcid=rss_sd_all
In Vitro Responsiveness of 417 CFTR Variants to Vanzacaftor/Tezacaftor/Ivacaftor. Journal of Cystic Fibrosis. https://www.sciencedirect.com/science/article/pii/S1569199326037318?dgcid=rss_sd_all
“In Vitro Responsiveness of 417 CFTR Variants to Vanzacaftor/Tezacaftor/Ivacaftor.” Journal of Cystic Fibrosis.
@article{article52953,
title = {In Vitro Responsiveness of 417 CFTR Variants to Vanzacaftor/Tezacaftor/Ivacaftor},
journal = {Journal of Cystic Fibrosis},
url = {https://www.sciencedirect.com/science/article/pii/S1569199326037318?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...